TAAR9 and renal carcinoma: In addition, TA3 has been reported to exert anti-cancer effects by inhibiting cell migration, invasion, and angiogenesis through various mechanisms in cancers such as lung cancer, liver cancer, breast cancer, renal cancer, and melanoma [31,32,33,34,35,36].